MONMOUTH JUNCTION, N.J., Sept. 16, 2019 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded DiamiR $345,000 in supplemental funding under the ongoing Small Business Innovation Research (SBIR) Phase IIB grant of $2,800,000 awarded in 2017. The award will further support development of the company’s targeted diagnostic technology for detection and prediction of progression of Alzheimer’s disease (AD).